<DOC>
	<DOCNO>NCT00877734</DOCNO>
	<brief_summary>This study efficacy safety baclofen alcohol dependence . 80 outpatient subject DSM-IV alcohol dependence randomize 10 mg three time day ( tid ) baclofen tid placebo . An effort make recruit 40 men 40 woman . Subjects receive BRENDA counsel 12 week trial . The Timeline Followback ( TLFB ) method use ass drinking pattern . The primary outcome % heavy drinking trial .</brief_summary>
	<brief_title>Efficacy Tolerability Baclofen Alcohol Dependence</brief_title>
	<detailed_description>The study explore efficacy tolerability 12-week regimen 10 mg t.i.d . baclofen vs. placebo conjunction behavioral therapy reduce heavy drinking 80 alcohol dependent individual . Prior study ( Addolorato et al . 2000 , 2002 ; Flannery et al. , 2004 ) find baclofen reduces self-reported anxiety craving ; therefore , propose study also assess baclofen 's ability reduce symptom affective state . Furthermore , pilot study ( Flannery et al , 2004 ) , woman appear respond consistently men , therefore study also balance gender .</detailed_description>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<criteria>Inclusion Criteria 1 . Men woman age 18 60 meeting DSMIV criterion current alcohol dependence . 2 . Must least 2 heavy drinking day ( men &gt; 5 drinks/days ; woman &gt; 4 drinks/day ) per week , average average overall consumption 21 drinks/week men 14 drinks/week woman 4 week prior screen . 3 . Able understand sign write informed consent . 4 . Must willing refrain drinking three day prior randomization day . 5 . Express desire achieve abstinence greatly reduce alcohol consumption . 6 . Must stable residence able identify individual could locate subject need . Exclusion Criteria 1 . Clinically significant medical disease might interfere evaluation study medication present safety concern ( e.g. , cirrhosis , kidney impairment , unstable hypertension , hypotension , diabetes mellitus , seizure disorder ) . 2 . Clinically significant psychiatric illness include psychotic disorder , bipolar disorder , severe depression ; suicidal ideation ; substance use disorder alcohol nicotine dependence cannabis abuse . 3 . History complicate alcohol withdrawal , i.e . withdrawal seizure delirium tremens . 4 . Concurrent use psychotropic medication include antidepressant , mood stabilizer , antipsychotic , anxiolytic , stimulant , hypnotic . However , subject stable dos antidepressant fluoxetine , sertraline , paroxetine , citalopram , ecitalapram , trazodone venlafaxine two month eligible . Subjects take benzodiazepine alcohol detoxification require washout period least five halflives ( approximately 5 day ) medication randomize . 5 . Concurrent use anticonvulsant , insulin , oral hypoglycemics . 6 . AST , ALT &gt; 3 time Upper Limit Normal ( ULN ) , bilirubin &gt; ULN , creatinine &gt; ULN . 7 . Positive urine toxicology screen exception cannabis . Individuals positive cannabis screen exclude history cannabis dependence . 8 . Pregnant woman woman childbearing potential practice medically acceptable form birth control ( oral depot contraceptive , barrier method diaphragm condom spermicidal ) . 9 . Women breastfeed . 10 . Individuals require inpatient treatment intense outpatient treatment alcohol dependence . 11 . Participation clinical trial within last 60 day . 12 . Courtmandated participation alcohol treatment pending incarceration .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>alcohol dependence</keyword>
	<keyword>baclofen</keyword>
	<keyword>pharmacotherapy</keyword>
	<keyword>woman</keyword>
</DOC>